A treatment of inhaled inorganic nitrite did not improve exercise capacity among patients with a common form of heart failure, according to a clinical trial published in JAMA.
Yearly Archives: 2018
Scientific images helped bring to life the discoveries made at Feinberg this year, from the origin of nitric oxide in the retina to mechanisms of herpes simplex virus infection. See a selection of some of the most stunning images.
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
Alumnus David Skorton, ‘74 MD, secretary of the Smithsonian Institution, has been named the president and CEO of the Association of American Medical Colleges.
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
Laszlo Lorand, PhD, professor emeritus of Cell and Molecular Biology and a distinguished scientist whose career spanned more than 60 years at Northwestern, passed away on December 6.
Northwestern Medicine professionals treated nearly 1,000 patients as part of a medical mission trip in late September.
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.